… supports lower bleeding risks with dabigatran over warfarin, … of bleeding risk reduction
with rivaroxaban compared with … Low-dose therapy is also recommended for apixaban doses …

… dabigatran, rivaroxaban, apixaban, edoxaban) are at least non-inferior in reducing the risks
of stroke and bleeding compared with warfarin. … of (1) low dose of dabigatran (110 mg twice a …

… bleeding were lower with apixaban and dabigatran and higher with rivaroxaban, each compared
with warfarin… ≥18 years initiating apixaban, rivaroxaban, dabigatran, or warfarin from 1 …

… (apixaban, dabigatran, edoxaban, rivaroxaban or warfarin) by their … their corresponding
thrombotic and bleeding risks.25 26 … Low-dose rivaroxaban (<20 mg daily) was associated with a …

… 15 for both aPCC and low-dose 4F-PCC and a GCS of 14 for high-dose 4F-PCC. The median
ICH score for patients with a spontaneous IPH was 1 in aPCC, 2 in low-dose 4F-PCC and …

… bleeding risks with apixaban and dabigatran compared with warfarin, but not for rivaroxaban…
Several studies combined results from both standard-dose DOAC and low-dose DOAC, …

… We compared stroke, bleeding, and mortality rates on and off therapy for standard and
low-dose DOACs (apixaban, rivaroxaban, dabigatran) versus warfarin in a Canadian cohort. We …

… that Apixaban was associated with lower risk of major and GI … bleeding, we found a similar
performance of Dabigatran with … number of events according to high and low dose of DOACs. …

… of low dose or standard dose and the risk of any bleeding … dabigatran, rivaroxaban or apixaban
with renal indication for … who qualify for low dose rivaroxaban and dabigatran if decisions …

… warfarin, GIB rates were similar between warfarin users and both apixaban and low-dose
dabigatran … The higher GIB risk of rivaroxaban compared to apixaban and dabigatran may be …